Apr 23 2024 17 mins
Pharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production. Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines.
Articles and videos on Switzerland's investment in Slovenia are available on swissinfo.ch. For other science stories from Switzerland please go to www.swissinfo.ch/science.
Journalist: Jessica Davis Plüss
Host: Jo Fahy
Audio editor/video journalist: Céline Stegmüller & Michele Andina
Distribution and Marketing: Xin Zhang
SWI swissinfo.ch is a Multilingual Public service media based in Bern, Switzerland.
SWI swissinfo.ch is a public service media company based in Bern Switzerland. It publishes independent news and information in 10 languages about Switzerland for a global audience.